Abstract
Consumption of probiotics in the form of fermented products has a long history. Since the last two decades, probiotics has gained the attention of the scientific community because of their health beneficial effects. Positive effects of probiotics on metabolic disorders such as nonalcoholic fatty liver disease, immune diseases, obesity, diabetes, insulin resistance, cardiovascular disease, irritable bowel syndrome, and inflammatory bowel disease have been reported, but exact mechanism of action of probiotics in amelioration of these disorders is yet to be elucidated. Generally, genera Lactobacillus and Bifidobacterium are employed as probiotics. Different probiotics act differently in conferring health beneficial effects. Moreover, health-promoting effects of probiotics are dependent on the strain. Furthermore, probiotic dosages, feeding schedule, mechanism of action, and long-term effects on health are yet to be elucidated. Therefore, further studies are required to explain the health beneficial effects of probiotics before it can be rationally prescribed to patients. In this chapter, we will discuss about role of probiotics in the prevention and treatment of various metabolic disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abuissa H, Bell DSH, O’Keefe JH (2005) Strategies to prevent type 2 diabetes. Curr Med Res Opin 21(7):1107–1114
Abu-Shanab A, Quigley EMM (2010) The role of the gut microbiota in non-alcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7(12):691–701
Altonsy MO, Andrews SC, Tuohy KM (2010) Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: mediation by the mitochondrial pathway. Int J Food Microbiol 137(2–3):190–203
Anila K, Kunzes A, Bhalla T (2016) In vitro cholesterol assimilation and functional enzymatic activities of putative probiotic lactobacillus sp isolated from fermented foods/beverages of north west india. J Nutr Food Sci 6(467):1–5
Aragon G, Graham DB, Borum M, Doman DB (2010) Probiotic therapy for irritable bowel syndrome. Gastroenterol Hepatol 6(1):39–44
Aronsson L, Huang Y, Parini P, Korach-André M, Håkansson J, Gustafsson J-Å, Pettersson S, Arulampalam V, Rafter J (2010) Decreased fat storage by Lactobacillus Paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 5(9):e13087
Arora T, Anastasovska J, Gibson G, Tuohy K, Sharma RK, Bell J, Frost G (2012) Effect of Lactobacillus acidophilus NCDC 13 supplementation on the progression of obesity in diet-induced obese mice. Br J Nutr 108(8):1382–1389
Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120–123
Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 27;157(1):121–141
Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME (2009) Probiotics and immunity. J Gasteroenterol 44(1):26–46
Cani PD, Delzenne NM (2009) Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 9(6):737–743
Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NMJD (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50(11):2374–2383
Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes 57(6):1470–1481
Coppack SW (2001) Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60(3):349–356
Ding S, Chi M, Scull B, Rigby R, Schwerbrock N, Magness S, Jobin C, Lund P (2010) High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5(8):e12191
Drago L (2019) Probiotics and Colon Cancer. Microorganisms 7(3):66
Eslami M, Yousefi B, Kokhaei P, Hemati M, Nejad ZR, Arabkari V, Namdar A (2019) Importance of probiotics in the prevention and treatment of colorectal cancer. J Cell Physiol 234:17127. https://doi.org/10.1002/jcp.28473
Fåk F, Bäckhed F (2012) Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe−/− mice. PLoS One 7(10):e46837
FAO/WHO (2002) Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada. (2002). April, May. Guidelines for evaluation of probiotics in food. FAO/WHO, Rome
Gill H, Prasad J (2008) Probiotics, immunomodulation, and health benefits. In: Bösze Z (ed) Bioactive components of milk. Springer New York, New York, pp 423–454
Greenberg AS, Obin MS (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83(2):461S–465S
Hamad EM, Sato M, Uzu K, Yoshida T, Higashi S, Kawakami H, Kadooka Y, Matsuyama H, El-Gawad IAA, Imaizumi K (2008) Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. Br J Nutr 101(5):716–724
Henao Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez J-P, Shulman GI, Gordon JI, Hoffman HM, Flavell RA (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179
Hendler R, Zhang Y (2018) Probiotics in the treatment of colorectal cancer. Medicines 5(3):101
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409–2415
Hsieh FC, Lee CL, Chai CY, Chen WT, Lu YC, Wu CS (2013) Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab 10(1):35
Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D (2015) Role of the normal gut microbiota. World J Gastroenterol 21(29):8787–8803
Jangra S, Sharma RK, Pothuraju R, Bhakri G (2019) Milk fermented with Lactobacillus casei NCDC19 improves high fat and sucrose diet alters gene expression in obese mice. Int Dairy J 90:15–22
Jin CW, Jin DH, Uk JH, Ho JH, Yeung-Hyen K, Hoon KT (2019) Antiobesity effects of Lactobacillus plantarum LMT1-48 accompanied by inhibition of enterobacter cloacae in the intestine of diet-induced obese mice. J Med Food 22(6):560–566. https://doi.org/10.1089/jmf.2018.4329
Kang JH, Yun SI, Park MH, Park JH, Jeong SY, Park HO (2013) Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One 8(1):e54617
Kim JJ, Sears DD (2010) TLR4 and insulin resistance. Gastroenterol Res Pract 2010:212563., 11 pages. https://doi.org/10.1155/2010/212563
Kim KA, Gu W, Lee IA, Joh EH, Kim DH (2012) High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 7(10):e47713
Kim KA, Jeong JJ, Kim DH (2015) Lactobacillus brevis OK56 ameliorates high-fat diet-induced obesity in mice by inhibiting NF-κB activation and gut microbial LPS production. J Funct Foods 13:183–191
Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WHW, Bushman FD, Lusis AJ, Hazen SL (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19(5):576–585
Kumar M, Kumar A, Nagpal R, Mohania D, Behare P, Verma V, Kumar P, Poddar D, Aggarwal PK, Henry CJK, Jain S, Yadav H (2010) Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr 61(5):473–496
Kumar M, Rakesh S, Nagpal R, Hemalatha R, Ramakrishna A, Sudarshan V et al (2013) Probiotic Lactobacillus rhamnosus GG and aloe vera gel improve lipid profiles in hypercholesterolemic rats. Nutrition 29:574–579
Kumar KS, Sastry N, Polaki H, Mishra V (2015) Colon cancer prevention through probiotics: an overview. J Can Sci Ther 7(2):081–092
Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee KE, Paek KS, Lee Y, Park JH (2006) Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta (BBA) – Mol Cell Biol Lipids 1761(7):736–744
Lee K, Paek K, Lee HY, Park JH, Lee Y (2007) Antiobesity effect of trans-10,cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. J Appl Microbiol 103(4):1140–1146
Lee DE, Kehlenbrink S, Lee H, Hawkins M, Yudkin JS (2009) Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab 296(6):E1210–E1229
Levine GN, Keaney JF, Vita JA (1995) Cholesterol reduction in cardiovascular disease – clinical benefits and possible mechanisms. N Engl J Med 332(8):512–521
Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102(31):11070–11075
Li H, Lelliott C, Håkansson P, Ploj K, Tuneld A, Verolin-Johansson M, Benthem L, Carlsson B, Storlien L, Michaëlsson E (2008) Intestinal, adipose, and liver inflammation in diet-induced obese mice. Metabolism 57(12):1704–1710
Lim S-M, Jeong J-J, Woo KH, Han MJ, Kim D-H (2016) Lactobacillus sakei OK67 ameliorates high-fat diet–induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutr Res 36(4):337–348
Ma X, Hua J, Li Z (2008) Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 49(5):821–830
Ma Y-Y, Li L, Yu C-H, Shen Z, Chen L-H, Li Y-M (2013) Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol 19(40):6911–6918
Marchetti P (2005) New-onset diabetes after liver transplantation: from pathogenesis to management. Liver Transpl 11(6):612–620
McLoughlin RM, Mills KHG (2011) Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol 127(5):1097–1107
Mennigen R, Bruewer M (2009) Effect of probiotics on intestinal barrier function. Ann NY Acad Sci 1165(1):183–189
Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D (2012) Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog 53(2):100–108
Miyoshi M, Ogawa A, Higurashi S, Kadooka Y (2014) Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr 53(2):599–606
Moreira APB, Texeira TFS, Ferreira AB, do Carmo Gouveia Peluzio M, de Cássia Gonçalves Alfenas R (2012) Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108(5):801–809
Nadler ST, Attie AD (2001) Please pass the chips: genomic insights into obesity and diabetes. J Nutr 131(8):2078–2081
Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, Matsuzaki T, Miyazaki K, Ishikawa F (2011) Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 110(3):650–657
Nell S, Suerbaum S, Josenhans C (2010) The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 8:564
Nguyen TDT, Kang JH, Lee MS (2007) Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int J Food Microbiol 113(3):358–361
Okubo T, Takemura N, Yoshida A, Sonoyama K (2013) KK/Ta mice administered Lactobacillus plantarum strain No. 14 have lower adiposity and higher insulin sensitivity. Biosci Microbiota, Food Health 32(3):93–100
Park Y, Kim J, Shin Y, Kim S, Whang K (2007) Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. J Microbiol Biotechnol 17:655e662
Park D-Y, Ahn Y-T, Park S-H, Huh C-S, Yoo S-R, Yu R, Sung M-K, McGregor RA, Choi M-S (2013) Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 8(3):e59470
Pothuraju R, Sharma RK, Chagalamarri J, Jangra S, Kumar Kavadi P (2014) A systematic review of Gymnema sylvestre in obesity and diabetes management. J Sci Food Agric 94(5):834–840
Pothuraju R, Rachagani S, Junker WM, Chaudhary S, Saraswathi V, Kaur S, Batra SK (2018) Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. J Exp Clin Cancer Res 37(1):319
Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S (2018) Gut dysbiosis and irritable bowel syndrome: the potential role of probiotics. J Infect 76(2):111–120
Qiao Y, Sun J, Xia S, Li L, Li Y, Wang P, Shi Y, Le G (2015) Effects of different Lactobacillus reuteri on inflammatory and fat storage in high-fat diet-induced obesity mice model. J Funct Foods 14:424–434
Rather SA, Pothuraju R, Sharma RK, De S, Mir NA, Jangra S (2014) Anti-obesity effect of feeding probiotic dahi containing Lactobacillus casei NCDC 19 in high fat diet-induced obese mice. Int J Dairy Technol 67(4):504–509
Salaj R, Stofilová J, Soltesová A, Hertelyová Z, Hijová E, Bertková I, Strojný L, Kružliak P, Bomba A (2013) The effects of two Lactobacillus plantarum strains on rat lipid metabolism receiving a high fat diet. Sci World J 2013:135142–135142
Scanlan PD, Shanahan F, Clune Y, Collins JK, O’Sullivan GC, O’Riordan M, Holmes E, Wang Y, Marchesi JR (2008) Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 10(3):789–798
Sears IB, MacGinnitie MA, Kovacs LG, Graves RA (1996) Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma. Mol Cel Biol 16(7):3410–3419
Serra MC, Ryan AS, Goldberg AP (2017) Reduced LPL and subcutaneous lipid storage capacity are associated with metabolic syndrome in postmenopausal women with obesity. Obes Sci Pract 3(1):106–114
Sharma A, Viswanath B, Park YS (2018) Role of probiotics in the management of lung cancer and related diseases: an update. J Funct Foods 40:625–633
Shin HS, Park SY, Lee DK, Kim SA, An HM, Kim JR, Kim MJ, Cha MG, Lee SW, Kim KJ, Lee KO, Ha NJ (2010) Hypocholesterolemic effect of sonication-killed Bifidobacterium longum isolated from healthy adult Koreans in high cholesterol fed rats. Arch Pharm Res 33(9):1425–1431
Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux J-J, Blugeon S, Bridonneau C, Furet J-P, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105(43):16731–16736
Tabuchi M, Tamura A, Yamada N, Ishida T, Hosoda M, Hosono A (2004) Hypocholesterolemic effects of viable and heat-sterilized cells of Lactobacillus GG in rats fed a high-cholesterol diet. Milchwissenschaft 59(5–6):249–253
Taylor RJD (2008) Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 51(10):1781–1789
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Aunola S, Cepaitis Z, Moltchanov V, Hakumäki M, Mannelin M, Martikkala V, Sundvall J, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343–1350
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031
Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI (2008) A core gut microbiome in obese and lean twins. Nature 457:480
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, Feldstein AE, Britt EB, Fu X, Chung Y-M, Wu Y, Schauer P, Smith JD, Allayee H, Tang WHW, DiDonato JA, Lusis AJ, Hazen SL (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472:57
Xie N, Cui Y, Yin Y-N, Zhao X, Yang J-W, Wang Z-G, Fu N, Tang Y, Wang X-H, Liu X-W, Wang C-L, Lu F-G (2011) Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement Altern Med 11:53–53
Yadav R, Vij R, Kapila S, Khan SH, Kumar N, Meena S, Kapila R (2019) Milk fermented with probiotic strains Lactobacillus rhamnosus MTCC5957 and Lactobacillus rhamnosus MTCC5897 ameliorates the diet-induced hypercholesterolemia in rats. Ann Microbiol 69(5):483–494
Yin Y-N, Yu Q-F, Fu N, Liu X-W, Lu F-G (2010) Effects of four bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol 16(27):3394–3401
Zanella MT, Ribeiro Filho FF (2009) Emerging drugs for obesity therapy. Arq Bras Endocrinol Metabol 53:271–280
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Jangra, S., Pothuraju, R. (2020). Living Medicines for Health and Disease Management. In: Sharma, S., Sharma, N., Sharma, M. (eds) Microbial Diversity, Interventions and Scope. Springer, Singapore. https://doi.org/10.1007/978-981-15-4099-8_18
Download citation
DOI: https://doi.org/10.1007/978-981-15-4099-8_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4098-1
Online ISBN: 978-981-15-4099-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)